chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Fever (~100-101), muscle aches starting late 4/29/21 - dissipated by 5/3/21. Headache & sinus pain w dry nasal passages, fatigue began 4/29/21 also and continue presently, though fatigue reduced. Early May 2021 the following symptoms began and not improved: Increased resting heart rate, transient palpitations, nightly chest pain, transient tinnitus, sinus congestion with dry nasal passages, nosebleeds 1-3x/week, pulse/pressure felt in neck up to temple on left side only, constant dry & scratchy eyes with transient minor ache- can no longer wear contacts.
Diarrhea, Vomiting - Doctor advised fluids.  2 day duration.
No symptoms reported however patient accidentally received two doses of Moderna COVID Vaccine on the same day Narrative:  Employee presented to COVID Vaccine clinic on 9/16/2021 for her 2nd dose of the two dose Moderna COVID vaccine series. Nurse attempted to give dose with blue safety needle. Stated needle wouldn't go in very far. Employee was thin and needle was long. Stated she couldn't push the plunger down and was meeting a lot of resistance so pulled needle out of employees arm. Got another nurse who got a different orange safety needle with a shorter needle and administered full dose of Moderna. After employee left when looking at both syringes they were both empty so we suspect employee got a double dose of Moderna vaccine for the 2nd dose of the series on 9/16/2021
CONFIRMED CLINICAL VACCINATION FAILURE; CONFIRMED COVID-19 INFECTION; This spontaneous report received from a consumer concerned a female of unspecified age, race and ethnicity. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 041A21A expiry: 21-JUN-2021) dose was not reported, 1 total, administered on 06-APR-2021 for covid-19 prophylaxis. No concomitant medications were reported. Non-company suspect drugs included: nirmatrelvir/ritonavir (Paxlovid) (form of admin, route of admin, and batch number were not reported) dose and frequency were not reported from MAR-2023 for covid-19 treatment.  On MAR-2023, the patient tested positive for covid and then again 17 days after Paxlovid treatment. Symptoms were mild (confirmed clinical vaccination failure, and confirmed covid-19 infection). Laboratory data included: COVID-19 virus test Positive, Positive. The action taken with covid-19 vaccine ad26.cov2.s was not applicable; and action taken with nirmatrelvir/ritonavir was not reported. The patient had not recovered from confirmed covid-19 infection, and the outcome of confirmed clinical vaccination failure was not reported. This report was serious (Other Medically Important Condition). This case, from the same reporter is linked to 20230351456. This report was associated with product quality complaint: 90000276278.; Sender's Comments: V0: 20230366649-confirmed clinical vaccination failure. The event has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There are other factors more likely to be associated with the event. Specifically: SPECIAL SITUATIONS. Therefore, this event is considered inconsistent with vaccine administration.
Contact transmission. Skin changes began 9 May. Previously vaccinated in 2008. Symptoms: HEADACHE (R51), RASH and OTH NON-SPEC SKIN ERUPTION (R21), MYALGIA (M791).
Initial and follow up information has been received from a physician concerning a 20 month old male patient, with no known allergies or pertinent medical history, who on 27-FEB-2007 was vaccinated subcutaneously with a 0.5 ml dose of ProQuad (Enders-Edmonston, Jeryl Lynn, Wistar RA 27/3, Oka/Merck upgrade process) (Lot#656444/1529F).  There was no concomitant therapy.  On 30-JUN-2007, while the patient was at the shore he developed a vesiculo-papular rash on his left arm following the dermatome pattern.  There was some redness at the base of the vesicles.  After one week (on approximately 07-JUL-2007) the patient was seen by the physician.  The physician noted that there was slight resolution, but the rash looked like zoster shingles.  The patient was prescribed hydroxyzine HCl for itch and discomfort.  The patient recovered.  The rash lasted ten days.  There was no product quality complaint involved.  No further information was provided.  No further information is expected.
EXPIRED VACCINE ADMINISTERED; This spontaneous report received from a pharmacist concerned a 67 year old female. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 203A21A, expiry: 21-SEP-2021) dose was not reported, administered on 03-OCT-2021 for prophylactic vaccination. No concomitant medications were reported. On 03-OCT-2021, the patient experienced expired vaccine administered. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of expired vaccine administered was not reported. This report was non-serious.
I woke up at 3:45am the morning after getting the vaccines with a pounding headache, shivering, achy all over and nauseated. I had a fever 100.9. I broke out in claims cold sweats. I have arm pain that burns to the touch that is rashy with a large deep red area. I took 2 excedrine that have lessened my headache and lowered by fever to 100. It is 8:00am 4 hours after my symptoms began. I feel weak and unwell.
A non-serious spontaneous report of fever, aches, weakness, a runny and congested nose, and cough has been received from a nurse concerning a 4-year-old female, subsequent to FLUMIST. This case is submitted in accordance with MedImmune's post-marketing commitment on accelerated reporting for the newly indicated population of 2 years to 59 months of age for FLUMIST. Neither relevant medical history nor concomitant medications have been reported for this patient.  On 24-Sep-2009, the patient received FLUMIST. The patient received a single dose before onset of the events. Two days after receiving FLUMIST, the patient developed fever, aches, weakness, a runny and congested and, more recently a cough. Outcome and causality were not reported.
Hives just below left butt check and right over underwear elastic on left lower abdomen.
The right upper arm was very painful when I barely moved it during the first night. The pain went  into the area of my chest that's near the arm. In the morning I noticed the area about 3" below the injection site to about 3" above the crease of my elbow was red, warm and swollen. The site of the injection was fine. It stayed like that for 2 days. It slowly got better and today (9/28)  it's just a little pink.
This spontaneous report was received from a physician refers to a multiple patients of unknown age and gender. No concurrent condition or medical history was reported. On an unknown date in October 2015, the patients were vaccinated with improperly stored dose (temperature: 11.7 F, time frame: 1 hour) of VARIVAX (Merck) (dose and route of administration not provided). No concomitant therapy was reported. No adverse effects were reported. The outcome of the event was unknown. No product quality issue was involved. This is one of the several reports from same reporter link. Additional information has been requested.
Patient is here today for evaluation of rash beginning underneath her breasts, and spreading to her upper chest and neck beginning 1 week ago (2-3 days after receipt of her second MMR and varicella vaccines on 1/7/19. She otherwise feels well and has no fever, chills, or joint pain. The rash is nonpruritic. No treatment thus far. No similar problems with previous vaccination. The patient was initially evaluated by nurse practitioner earlier today and referred to me for further evaluation. Otherwise, she denies any new household or cosmetic products. Skin: Under the breast, with extension into the axillary and onto the neck there is maculopapular rash without vesiculation. see photos tab of pt's EMR.
Drowsy/drowsiness; arm soreness/soreness in his arm; exhausted; This is a spontaneous report received from a contactable consumer (patient wife). A male patient (husband) of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) via an unspecified route of administration on an unspecified date (Batch/Lot Number: Not Provided) as single dose for COVID-19 immunization. The patient medical history and concomitant medications were not reported. Patient had drowsiness and arm soreness/soreness in his arm after receiving the Covid-19 Vaccine. Patient was immediately drowsy and falling asleep after he got the COVID-19 vaccine. Patient wife drove them both home, and patient slept on the way home with the seat back. He was exhausted anyway because of work. It hit him harder than her. He went into the first floor bedroom and laid down. Outcome of the events was unknown.   No follow-up attempts possible; information about lot/batch number cannot be obtained.
After 6 hours that I had been vaccinated, I had welts like an allergy appear on both hands and they itched.
Patient began to feel ill about 4 hours after the shot.  Symptoms started as head to toe muscle pain, severe headache, leg spasms, nausea, and unable to bend fingers.  Symptoms persisted for 3 days.  Rash at injection site appeared 4 days post immunization and disappeared within 48 hours.
Headache, Myalgia, Fever, Diarrhea, NauseaVomiting, GENERAL MALAISE/SORENESS IN ARM/TENDER LYMPHNODES IN ARMPIT/CHILLS Narrative:
Information has been received from a registered nurse, concerning a 7 year old male patient, with no medical history or medicines and no allergies, who on 23-JUL-2004, was vaccinated subcutaneously with a 0.5 mL dose of VARIVAX (Merck) (lot number not reported). On 20-APR-2010, the patient received intramuscularly the second 0.5 mL of VARIVAX (Merck) (lot number 665882/1409Y). No other vaccines administered the same day. On 20-APR-2010, before leaving the exam room, the patient fainted. The patient recovered right away and with no apparent injury. No labs or diagnostics studies were performed. The patient sought unspecified medical attention. This is one of several reports concerning siblings received from the same source (MSD, WAES# 1004USA03467). Follow-up information has been received from the nurse practitioner, who reported that the patient was in office for his well child examination on 20-APR-2010 and for immunization update of second varicella, which received at 9:00 am in the left deltoid. The nurse reported that the patient was in good health and had no complaints, physical examination completed, the patient was given his varicella immunization without incident. After observing that his brother had a syncopal episode following immunization, the patient was instructed to rest in a chair. The patient verbalized no concerns until he was "thirsty". The patient was instructed not to drink the water from the tap due to its taste and he continued to sit in the chair but repeated he was thirsty and then said "I don't feel good". The patient slumped back into the chair and then drew his extremities inward. His mother and a licensed practical nurse, lowered him to the floor and placed him in recovery position. The patient remained unconscious for approximately 20 seconds and then abruptly opened his eyes. The patient stated "I feel asleep and now I am on the floor". The patient was instructed to remain quiet, vital signs were stable at tympanic temperature of 96.9. 108 apical pulse 108 and blood pressure 96/60. His color returned to normal. The patient was mildly diaphoretic. He continued to improve under observation, was given a small cup of spring water he drank. The patient returned to sitting in the chair, looked mildly confused but answered questions appropriately. Upon standing to leave, the patient became more ashen, stated that he had a "tickle in the throat" and then projectile vomited water twice. The patient returned to the chair and regained his color. The patient then stated "I feel fine now". He was allowed to rest for several additional minutes and then ambulated from the waiting room to the car with escort. No further information is available.
Patient had redness and swelling x 1 wk. Headache, joint and muscle pain. There is still pain in the knee and hard to walk.
Injection site itching; 20 hours later a large lump startedappearing; Injection site red; Injection site warmth; Initial pain at injection site; Injection site tenderness; This is a spontaneous report from a contactable consumer, the patient. A 25-years-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN8727) via an unspecified route of administration in the left arm on 27Mar2021 at 18:45 (at the age of 25-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medication were not reported. The patient was allergy to pineapple. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6199) via an unspecified route of administration in the left arm on 6Mar2021 at 18:30 (at the age of vaccination 25-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 28Mar2021 at 00:00 the patient experienced initial pain at injection site but after 14:45 (about 20 hours later) a large lump started appearing, it was very red and warm to the touch, it grew to about a 3-inch diameter on 29Mar2021 at 18:45 (over the next 48 hours) and started to itch. The patient did not receive any treatment for the event.  The adverse event did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events pain at injection site, injection site red, injection site warmth and injection site itching were resolving (redness and itch started to go down after about 2 days); whereas for event injection site large lump and injection site tenderness were not resolved (still a hard bump with the diameter a little larger than a dime and it is tender to touch) at the time of this report.  No follow-up attempts are needed. No further information is expected.
Went home from receiving the immunization and was tired/exhausted (had been fine that day prior to immunization) and had a fever for 3 days. The day after he received the immunization he developed "hives" on the outside of his neck.  2 days after receiving the immunizations he had swelling on the inside of his throat, he could not swallow his spit or water and had trouble talking. He was able to breath but it was labored and he had to keep his head back and his chin up. This lasted for a few hours. They were ono vacation and  not in a location that had medical care so they packed up and headed in to town. By the time they got to a place with medical care it was resolving.
bilateral episcleritis, blurry vision, pressure sensation, facial rash, increased body temperature (99.6-100.4), bilateral hand & foot inflammatory pain (lasting 2 weeks), pain disturbed sleep, shortness of breath due to pain, chest pain, numbness in foot when walking, joint inflammation.
This spontaneous report as received from a nurse refers to an unspecified patients of unknown age and gender. The patient pertinent medical history and concurrent conditions were not reported. No previous drug reactions or allergies were reported. On an unknown date the patients were vaccinated with VARIVAX (Merck) (dosing details were not reported) lot # L037560 expiry date 29-SEP-2017 which was exposed to a temperature of 6.1 degrees F for a time frame of 3 hour, no previous temperature excursion was reported. No concomitant medications were reported. No adverse effects were reported. There was no product quality complaint involved. This is one of the two reports received from the same reporter. Additional information has been requested.
Pt reported feeling "intense pain" in (L) deltoid injection site with administration. Pt reported pain "like never before" when received flu vaccine. States pain in (L) arm limited ability to abduct LUE to dress self x 2-3 days. States pain in (L) arm remains painful with lifting after 6 days. But pain has lessened. Pt counseled to see primary MD for evaluation ASAP.
TEMPERATURE EXCURSION OCCURRED DUE TO THE PLACEMENT OF HAND WARMERS IN THE INSULATED BAG USED TO TRANSPORT VACCINE. ALL 81 PERSONS RECEIVING VACCINE IN LANES 5 AND 6 AT THE  ON 02/15/2021 BETWEEN 14:00 and 16:45 WERE NOTIFIED THEY  RECEIVED VACCINE THAT WAS OUTSIDE OF THE APPROPRIATE TEMPERATURE RANGE AND WERE RECOMMENDED TO BE REVACCINATED.
The patient was supposed to receive a second 0.5 ml dose of moderna but was given a booter dose of  0.25ml moderna
8 days before admission to hosp, pt diagnosed positive for COVID; received antibiotic infusion on 9/2; O2 sats @ home were in the 60 -70s; went for x-ray today @ walk-in clinic and O2 sats were in the 80s; EMS transported pt to ED; hx of COPD, DM, HTN, CKD3; given remdisivir; placed on BiPAP; admitted to ICU where he eventually was intubated; condition deteriorated and comfort measures were requested; pt was extubated and passed away in the hosp
Our 7 month old baby got her 6 month shots and started diarrheaing that same night. She got blisters on her butt despite us constantly applying diaper cream. She was taken to Dr. on Monday March, 8th and they took a stool sample. The sample came back positive for rotavirus. She is STILL diarrheaing 2 weeks later. We are having to wash her in the sink every time she poops (which is 6-10 times per day) to lessen the severity of her rash.
Pt was administered flucelvax on the left arm. She was fine during and a few minutes after receiving the vaccination. When she stood up and left the immunization room, she felt dizzy and sat down on the bench. She did not fall or hurt herself.  She threw up after having some water, along with cold sweat and pale color skin. After getting some rest on the bench, around 15 minutes, she felt fine and left with her father. Her father declined to for us to call for any help.
discomfort in my sternum; trouble breathing; chest congestion; increased weakness; shakiness in my legs; Within 10mins I was feeling dizzy; increase palpitation; I told the nurse she checked my blood pressure. It was 157/87; This is a spontaneous report from a contactable healthcare professional (patient). A 47-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; batch/lot number and expiration date unknown), via an unspecified route of administration on the right arm on 15Jan2021 15:45 at a single dose for an COVID-19 immunization at a hospital. Medical history included GERD. There were no concomitant medications. On 15Jan2021 at 15:45 (reported as within 10 mins), the patient felt dizzy and increase palpitation. The patient told the nurse and she checked her blood pressure, it was 157/87. After 15 mins of vaccine infusion (16:00), she came back home and increased weakness with shakiness in legs noted. After 2 hrs. (18:00) all symptoms were gone. The next morning (16Jan2021), the patient had discomfort in her sternum. By late afternoon, she had trouble breathing with chest congestion. The patient took 3 puffs of inhaler so she can breathe. The patient mentioned that her inhaler is expired, it was given to her 3 years ago. She didn't want to use it but used it anyway so she can sleep. The events dizzy, palpitation, blood pressure high, weakness, shakiness, and discomfort in sternum were not treated. The outcome of the events weakness and shakiness was recovered on 15Jan2021 at 18:00 while the other events were unknown.  Information about lot/batch number has been requested.
breaking pain across her upper back; bad headache; tiredness; tasted the vaccine in her throat; throat felt dry; achy; This spontaneous case was reported by a consumer and describes the occurrence of DYSGEUSIA (tasted the vaccine in her throat), DRY THROAT (throat felt dry), PAIN (achy), BACK PAIN (breaking pain across her upper back) and HEADACHE (bad headache) in a 49-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026L2OA.) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event.    On 09-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Jan-2021, the patient experienced DYSGEUSIA (tasted the vaccine in her throat), DRY THROAT (throat felt dry), PAIN (achy), HEADACHE (bad headache) and FATIGUE (tiredness). On 12-Jan-2021, the patient experienced BACK PAIN (breaking pain across her upper back). At the time of the report, DYSGEUSIA (tasted the vaccine in her throat), DRY THROAT (throat felt dry), PAIN (achy), BACK PAIN (breaking pain across her upper back), HEADACHE (bad headache) and FATIGUE (tiredness) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment medication not provided. Concomitant medication not provided.
Confusion,  Admitted to Hospital on 2/12/21 Noted to have siezures
She reported her arm started hurting the day after the vaccine and it has not gone away.  she said her hand feels week and the pain is increasing.  she feels like she is loosing strength.  she has not  yet seen a doctor for this issue and it was recommended she follow up with a PCP
This patient received the smallpox, anthrax, and typhoid vaccines and two days later developed an itching rash which developed into a fever.  The patient then went to the emergency room three days later and also complained of a swollen, scratchy throat with difficulty swallowing.
Patient with 3 COVID vaccines who admitted with necrotizing fasciitis with incidental COVID detected PCR found during routine admission testing.  Asymptomatic for COVID. Patient expired 5 days after discharge.
PATIENT DESCRIBED HER LEFT UPPER ARM BEING HOT WITH FEVER AND VERY ICHY WITH A BURNING AND STINGING SENSATION WITH SWELLING THE SYMPTOMS HAVE BEEN PROGESSING SINCE THE 27TH OF APRIL.
Fatigue; This is a spontaneous report received from a contactable consumer (patient). A 76-year-old male patient received the 2nd dose of bnt162b2 (BNT162B2, Manufacturer Pfizer-BioNTech) (lot# EL8982), via an unspecified route of administration in left deltoid, on 28Jan2021 at 11:45 AM, at single dose, for COVID-19 immunisation. The patient's medical history was not reported. Concomitant medications included losartan (unknown manufacturer) from 2009 and ongoing, alopurinol (unknown manufacturer) from 1980 and ongoing, omeprazole (unknown manufacturer) from 2012 and ongoing, amlodipine besilate (unknown manufacturer) from 2010 and ongoing, cetirizine hydrochloride (CETIRIZINE) from 1998 and ongoing, atorvastatin calcium (unknown manufacturer) from 2019 and ongoing. The patient previously took the 1st dose of bnt162b2 (BNT162B2, Manufacturer Pfizer-BioNTech, Lot# EJ1686) on 04Jan2021 at 03:00 PM, for COVID-19 immunisation and experienced mild soreness/arm sore/soreness in the arm and fatigue. Previously the patient received 1 pill of naproxen sodium (ALEVE) on 04Jan2021 to anticipate fever and pain. The patient experienced fatigue (non-serious) on 28Jan2021 with outcome of recovered in 2021. No therapeutic measures were taken as a result of the event.